Medical Xpress news
Medical Xpress / Why deadly ovarian cancers hide from the immune system, and how to stop them
More than two-thirds of deaths from ovarian cancer are attributable to high-grade serous carcinoma. In one particularly aggressive form, only a small number of inactive immune cells can be found near the tumor. Such tumors ...
Medical Xpress / Why leaving things unfinished messes with your mind
There's a personal story that Yale psychologist Brian Scholl often shares when he explains his scholarly interest in the vexing power of what he calls "unfinishedness," or that nagging frustration you experience when tasks ...
Medical Xpress / Clinical trial in Ethiopia targets the trachoma scourge
Trachoma is the leading cause of infectious blindness in the world, with Ethiopia the most impacted country in Africa. In a clinical trial of more than 2,400 individuals, researchers led by Dr. John Kempen of Mass Eye and ...
Medical Xpress / Toddlers in England spending two hours on screens a day, doubling recommended screen time
Two-year-olds in England watch television, videos or other digital content for an average of two hours each day, double the daily recommended screen time, new UCL-led research finds.
Medical Xpress / New brain study explains how binge drinking contributes to long-lasting negative feelings
New research has identified that neuroinflammation driven by microglia (immune cells in the brain) is a primary underlying driver of prolonged negative feelings caused by repeated, sustained binge drinking (binge exposure). ...
Medical Xpress / Uncovering how occludin protein maintains blood-brain and blood-retinal barriers
The blood-brain and blood-retinal barriers are protective systems that prevent harmful substances from entering the brain and eyes. These barriers are created by cells that are joined tightly together by proteins. Dysfunctional ...
Medical Xpress / Whole-genome sequencing may optimize PARP inhibitor use for cancer patients
A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP inhibitor cancer treatments, according to a study led by Weill Cornell Medicine ...
Medical Xpress / Gut bacteria protect mice with influenza A from bacterial pneumonia, study finds
Select gut bacteria protect mice against post-influenza virus secondary bacterial pneumonia, according to a study published by researchers in the Institute for Biomedical Sciences at Georgia State University.
Medical Xpress / AI-driven insurance decisions raise concerns about human oversight
As health insurers increasingly turn to AI, researchers explore the promise of efficiency—and the risk of amplifying existing flaws.
Medical Xpress / Axonal protein synthesis defect identified as potential early driver in ALS progression
Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production, a process that fails in amyotrophic lateral sclerosis (ALS). The study, published in Nature Neuroscience, ...
Medical Xpress / Intraoperative tumor histology may enable more-effective cancer surgeries
The first line of treatment for cancer is, whenever possible, to remove the cancerous tissue from the body. Though often remarkably effective, removing only the cancerous tissue is a challenge for doctors and surgeons. With ...
Medical Xpress / Many head and neck cancer trials end early. Why?
Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most common reasons are sponsor decisions related to safety or effectiveness and poor patient recruitment.